Raghuram Selvaraju
Stock Analyst at HC Wainwright & Co.
(2.09)
# 1,548
Out of 4,502 analysts
663
Total ratings
41.06%
Success rate
n/a
Average return
Main Sectors:
90 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOTH Hoth Therapeutics | Reiterates: Buy | $4 | $0.81 | +393.83% | 4 | Jul 26, 2024 | |
| AQST Aquestive Therapeutics | Reiterates: Buy | $9 | $3.45 | +160.87% | 17 | Jul 26, 2024 | |
| RAPT RAPT Therapeutics | Reiterates: Neutral | n/a | $3.12 | - | 17 | Jul 23, 2024 | |
| KZR Kezar Life Sciences | Maintains: Buy | $20 → $7 | $0.66 | +963.34% | 13 | Jul 22, 2024 | |
| ACRS Aclaris Therapeutics | Reiterates: Neutral | n/a | $1.35 | - | 12 | Jul 22, 2024 | |
| GMAB Genmab | Reiterates: Buy | $50 | $28.13 | +77.75% | 35 | Jul 18, 2024 | |
| ANVS Annovis Bio | Reiterates: Buy | $30 | $10.47 | +186.53% | 15 | Jul 17, 2024 | |
| RGLS Regulus Therapeutics | Reiterates: Buy | $10 | $1.76 | +468.18% | 13 | Jul 16, 2024 | |
| ONCT Oncternal Therapeutics | Reiterates: Buy | $19 | $6.86 | +176.97% | 12 | Jul 16, 2024 | |
| CDXC ChromaDex | Reiterates: Buy | $6 | $3.19 | +88.09% | 13 | Jul 15, 2024 | |
| INO Inovio Pharmaceuticals | Reiterates: Neutral | $15 | $10.95 | +36.99% | 4 | Jul 15, 2024 | |
| ABEO Abeona Therapeutics | Reiterates: Buy | $15 | $5.03 | +198.21% | 5 | Jul 12, 2024 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $14 | $1.26 | +1,011.11% | 14 | Jul 11, 2024 | |
| GANX Gain Therapeutics | Reiterates: Buy | $8 | $1.04 | +669.23% | 15 | Jul 11, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $4 | $1.47 | +172.11% | 1 | Jul 3, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $3 | $1.06 | +183.02% | 4 | Jul 2, 2024 | |
| VRNA Verona Pharma | Reiterates: Buy | $36 | $22.15 | +62.53% | 17 | Jul 1, 2024 | |
| URGN UroGen Pharma | Reiterates: Buy | $60 | $16.36 | +266.75% | 20 | Jul 1, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $100 | $44.91 | +122.67% | 22 | Jul 1, 2024 | |
| TRDA Entrada Therapeutics | Maintains: Buy | $20 → $18 | $17.10 | +5.26% | 8 | Jun 25, 2024 | |
| BBIO BridgeBio Pharma | Reiterates: Buy | $43 | $26.70 | +61.05% | 10 | Jun 20, 2024 | |
| PYPD PolyPid | Reiterates: Buy | $14 | $3.50 | +300.00% | 4 | Jun 18, 2024 | |
| SCLX Scilex Holding Company | Reiterates: Buy | $7 | $1.70 | +311.76% | 6 | Jun 17, 2024 | |
| INDP Indaptus Therapeutics | Reiterates: Buy | $12 | $2.44 | +391.80% | 11 | Jun 17, 2024 | |
| PCSA Processa Pharmaceuticals | Reiterates: Buy | $8 | $1.66 | +381.58% | 3 | Jun 12, 2024 | |
| ENLV Enlivex Therapeutics | Maintains: Buy | $7 → $6 | $1.39 | +331.65% | 10 | Jun 11, 2024 | |
| AVXL Anavex Life Sciences | Reiterates: Buy | $40 | $6.84 | +484.80% | 16 | Jun 11, 2024 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $190 | $85.98 | +120.98% | 20 | Jun 6, 2024 | |
| SPRB Spruce Biosciences | Reiterates: Neutral | n/a | $0.54 | - | 10 | Jun 5, 2024 | |
| EQ Equillium | Reiterates: Buy | $5 | $0.80 | +525.00% | 10 | Jun 5, 2024 | |
| ENTX Entera Bio | Reiterates: Buy | $10 | $1.74 | +474.71% | 11 | Jun 5, 2024 | |
| BWAY BrainsWay | Reiterates: Buy | $15 | $7.65 | +96.08% | 15 | Jun 5, 2024 | |
| MBOT Microbot Medical | Reiterates: Buy | $7 | $0.99 | +607.14% | 6 | Jun 3, 2024 | |
| CGTX Cognition Therapeutics | Initiates: Buy | $10 | $2.10 | +376.19% | 1 | May 29, 2024 | |
| RKDA Arcadia Biosciences | Maintains: Buy | $10 → $6 | $2.86 | +109.79% | 11 | May 23, 2024 | |
| SLGL Sol-Gel Technologies | Reiterates: Buy | $6 | $0.45 | +1,233.63% | 15 | May 22, 2024 | |
| ORMP Oramed Pharmaceuticals | Reiterates: Neutral | n/a | $2.54 | - | 4 | May 20, 2024 | |
| LGVN Longeveron | Reiterates: Buy | $12 | $3.04 | +294.74% | 3 | May 17, 2024 | |
| FATE Fate Therapeutics | Maintains: Neutral | $7 → $5 | $5.40 | -7.41% | 3 | May 16, 2024 | |
| RMTI Rockwell Medical | Reiterates: Buy | $9 | $1.85 | +386.49% | 17 | May 16, 2024 | |
| SPRO Spero Therapeutics | Reiterates: Buy | $7 | $1.42 | +394.70% | 13 | May 16, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $18 → $15 | $6.61 | +126.93% | 9 | May 15, 2024 | |
| COCP Cocrystal Pharma | Reiterates: Buy | n/a | $2.22 | - | 13 | May 14, 2024 | |
| ADMA ADMA Biologics | Maintains: Buy | $7.5 → $10 | $13.08 | -23.55% | 13 | May 10, 2024 | |
| BTAI BioXcel Therapeutics | Reiterates: Buy | $10 | $1.17 | +754.70% | 30 | May 10, 2024 | |
| BCPC Balchem | Maintains: Buy | $167 → $170 | $174.81 | -2.75% | 14 | May 6, 2024 | |
| CRDF Cardiff Oncology | Reiterates: Buy | $14 | $2.37 | +491.97% | 12 | May 6, 2024 | |
| CING Cingulate | Maintains: Buy | $3.5 → $8 | $0.38 | +2,005.26% | 3 | Jan 5, 2024 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $10 | $3.57 | +180.11% | 9 | Dec 11, 2023 | |
| PXMD PaxMedica | Initiates: Buy | $3 | $0.24 | +1,150.00% | 1 | Dec 4, 2023 | |
| PLX Protalix BioTherapeutics | Reiterates: Buy | $10 | $1.15 | +769.57% | 4 | Nov 14, 2023 | |
| AEZS Aeterna Zentaris | Maintains: Buy | $112 → $60 | $5.54 | +983.03% | 10 | Nov 13, 2023 | |
| GLTO Galecto | Downgrades: Neutral | n/a | $0.56 | - | 5 | Sep 28, 2023 | |
| ENSC Ensysce Biosciences | Maintains: Buy | $9 → $7 | $0.41 | +1,594.92% | 2 | Sep 25, 2023 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Buy | $6 | $2.20 | +172.73% | 2 | Sep 25, 2023 | |
| GRTX Galera Therapeutics | Downgrades: Neutral | $6 → $0.3 | $0.13 | +140.00% | 6 | Aug 16, 2023 | |
| EVFM Evofem Biosciences | Maintains: Buy | $250 → $500 | $0.01 | +4,237,188.14% | 6 | Aug 15, 2022 | |
| ADXN Addex Therapeutics | Downgrades: Neutral | n/a | $8.34 | - | 4 | Jun 23, 2022 | |
| TYRA Tyra Biosciences | Initiates: Buy | $12 | $20.35 | -41.03% | 1 | Jun 23, 2022 | |
| INM InMed Pharmaceuticals | Initiates: Buy | n/a | $0.28 | - | 1 | Nov 29, 2021 | |
| OMER Omeros | Maintains: Buy | n/a | $5.28 | - | 4 | Oct 19, 2021 | |
| SYBX Synlogic | Maintains: Buy | n/a | $1.68 | - | 2 | Oct 13, 2021 | |
| RDHL RedHill Biopharma | Maintains: Buy | n/a | $0.38 | - | 2 | Sep 15, 2021 | |
| IMUX Immunic | Maintains: Buy | n/a | $1.39 | - | 3 | Sep 7, 2021 | |
| XCUR Exicure | Maintains: Buy | n/a | $0.50 | - | 1 | May 17, 2021 | |
| RGEN Repligen | Maintains: Buy | n/a | $132.36 | - | 5 | May 5, 2021 | |
| BHC Bausch Health Companies | Maintains: Buy | n/a | $5.88 | - | 4 | Mar 16, 2021 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $775 → $925 | $1.77 | +52,174.65% | 2 | Mar 5, 2021 | |
| NRBO NeuroBo Pharmaceuticals | Maintains: Buy | $4,800 → $3,840 | $4.10 | +93,672.89% | 2 | Feb 1, 2021 | |
| APDN Applied DNA Sciences | Maintains: Buy | $360 → $280 | $0.43 | +65,782.35% | 5 | Jan 14, 2021 | |
| CDNA CareDx | Maintains: Buy | n/a | $18.87 | - | 3 | Aug 5, 2020 | |
| CYDY CytoDyn | Downgrades: Neutral | n/a | $0.14 | - | 1 | Jul 6, 2020 | |
| REPL Replimune Group | Downgrades: Neutral | n/a | $10.48 | - | 1 | Jul 1, 2020 | |
| IGMS IGM Biosciences | Initiates: Buy | n/a | $12.10 | - | 1 | Jul 1, 2020 | |
| EVOK Evoke Pharma | Upgrades: Buy | n/a | $0.48 | - | 2 | Jun 22, 2020 | |
| BLFS BioLife Solutions | Maintains: Buy | n/a | $23.03 | - | 1 | Mar 23, 2020 | |
| SWTX SpringWorks Therapeutics | Upgrades: Buy | n/a | $36.87 | - | 1 | Mar 19, 2020 | |
| CELC Celcuity | Initiates: Buy | n/a | $19.15 | - | 1 | Nov 20, 2018 | |
| CTMX CytomX Therapeutics | Initiates: Buy | n/a | $1.42 | - | 1 | Sep 13, 2018 | |
| KALA Kala Pharmaceuticals | Maintains: Buy | n/a | $7.24 | - | 1 | Aug 24, 2018 | |
| CRMD CorMedix | Maintains: Buy | n/a | $4.71 | - | 1 | May 23, 2018 | |
| CHEK Check-Cap | Maintains: Buy | n/a | $2.02 | - | 1 | May 23, 2018 | |
| TTOO T2 Biosystems | Maintains: Buy | $40,000 → $42,500 | $4.83 | +879,817.18% | 2 | Mar 29, 2018 | |
| DRRX DURECT | Upgrades: Buy | n/a | $1.65 | - | 3 | Mar 6, 2018 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | n/a | $26.43 | - | 3 | Mar 5, 2018 | |
| AEMD Aethlon Medical | Initiates: Buy | n/a | $0.38 | - | 1 | Nov 20, 2017 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $18,000 → $6,000 | $1.77 | +338,061.53% | 1 | Nov 13, 2017 | |
| IMRN Immuron | Initiates: Buy | n/a | $2.29 | - | 1 | Oct 18, 2017 | |
| OCUL Ocular Therapeutix | Initiates: Buy | n/a | $8.28 | - | 1 | Jul 26, 2017 | |
| ALIM Alimera Sciences | Initiates: Buy | n/a | $5.59 | - | 1 | Apr 27, 2017 |
Hoth Therapeutics
Jul 26, 2024
Reiterates: Buy
Price Target: $4
Current: $0.81
Upside: +393.83%
Aquestive Therapeutics
Jul 26, 2024
Reiterates: Buy
Price Target: $9
Current: $3.45
Upside: +160.87%
RAPT Therapeutics
Jul 23, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.12
Upside: -
Kezar Life Sciences
Jul 22, 2024
Maintains: Buy
Price Target: $20 → $7
Current: $0.66
Upside: +963.34%
Aclaris Therapeutics
Jul 22, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.35
Upside: -
Genmab
Jul 18, 2024
Reiterates: Buy
Price Target: $50
Current: $28.13
Upside: +77.75%
Annovis Bio
Jul 17, 2024
Reiterates: Buy
Price Target: $30
Current: $10.47
Upside: +186.53%
Regulus Therapeutics
Jul 16, 2024
Reiterates: Buy
Price Target: $10
Current: $1.76
Upside: +468.18%
Oncternal Therapeutics
Jul 16, 2024
Reiterates: Buy
Price Target: $19
Current: $6.86
Upside: +176.97%
ChromaDex
Jul 15, 2024
Reiterates: Buy
Price Target: $6
Current: $3.19
Upside: +88.09%
Inovio Pharmaceuticals
Jul 15, 2024
Reiterates: Neutral
Price Target: $15
Current: $10.95
Upside: +36.99%
Abeona Therapeutics
Jul 12, 2024
Reiterates: Buy
Price Target: $15
Current: $5.03
Upside: +198.21%
Reviva Pharmaceuticals Holdings
Jul 11, 2024
Reiterates: Buy
Price Target: $14
Current: $1.26
Upside: +1,011.11%
Gain Therapeutics
Jul 11, 2024
Reiterates: Buy
Price Target: $8
Current: $1.04
Upside: +669.23%
Assertio Holdings
Jul 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.47
Upside: +172.11%
Ovid Therapeutics
Jul 2, 2024
Reiterates: Buy
Price Target: $3
Current: $1.06
Upside: +183.02%
Verona Pharma
Jul 1, 2024
Reiterates: Buy
Price Target: $36
Current: $22.15
Upside: +62.53%
UroGen Pharma
Jul 1, 2024
Reiterates: Buy
Price Target: $60
Current: $16.36
Upside: +266.75%
MoonLake Immunotherapeutics
Jul 1, 2024
Reiterates: Buy
Price Target: $100
Current: $44.91
Upside: +122.67%
Entrada Therapeutics
Jun 25, 2024
Maintains: Buy
Price Target: $20 → $18
Current: $17.10
Upside: +5.26%
BridgeBio Pharma
Jun 20, 2024
Reiterates: Buy
Price Target: $43
Current: $26.70
Upside: +61.05%
PolyPid
Jun 18, 2024
Reiterates: Buy
Price Target: $14
Current: $3.50
Upside: +300.00%
Scilex Holding Company
Jun 17, 2024
Reiterates: Buy
Price Target: $7
Current: $1.70
Upside: +311.76%
Indaptus Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $12
Current: $2.44
Upside: +391.80%
Processa Pharmaceuticals
Jun 12, 2024
Reiterates: Buy
Price Target: $8
Current: $1.66
Upside: +381.58%
Enlivex Therapeutics
Jun 11, 2024
Maintains: Buy
Price Target: $7 → $6
Current: $1.39
Upside: +331.65%
Anavex Life Sciences
Jun 11, 2024
Reiterates: Buy
Price Target: $40
Current: $6.84
Upside: +484.80%
Axsome Therapeutics
Jun 6, 2024
Reiterates: Buy
Price Target: $190
Current: $85.98
Upside: +120.98%
Spruce Biosciences
Jun 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.54
Upside: -
Equillium
Jun 5, 2024
Reiterates: Buy
Price Target: $5
Current: $0.80
Upside: +525.00%
Entera Bio
Jun 5, 2024
Reiterates: Buy
Price Target: $10
Current: $1.74
Upside: +474.71%
BrainsWay
Jun 5, 2024
Reiterates: Buy
Price Target: $15
Current: $7.65
Upside: +96.08%
Microbot Medical
Jun 3, 2024
Reiterates: Buy
Price Target: $7
Current: $0.99
Upside: +607.14%
Cognition Therapeutics
May 29, 2024
Initiates: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%
Arcadia Biosciences
May 23, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $2.86
Upside: +109.79%
Sol-Gel Technologies
May 22, 2024
Reiterates: Buy
Price Target: $6
Current: $0.45
Upside: +1,233.63%
Oramed Pharmaceuticals
May 20, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.54
Upside: -
Longeveron
May 17, 2024
Reiterates: Buy
Price Target: $12
Current: $3.04
Upside: +294.74%
Fate Therapeutics
May 16, 2024
Maintains: Neutral
Price Target: $7 → $5
Current: $5.40
Upside: -7.41%
Rockwell Medical
May 16, 2024
Reiterates: Buy
Price Target: $9
Current: $1.85
Upside: +386.49%
Spero Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $7
Current: $1.42
Upside: +394.70%
Fennec Pharmaceuticals
May 15, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $6.61
Upside: +126.93%
Cocrystal Pharma
May 14, 2024
Reiterates: Buy
Price Target: n/a
Current: $2.22
Upside: -
ADMA Biologics
May 10, 2024
Maintains: Buy
Price Target: $7.5 → $10
Current: $13.08
Upside: -23.55%
BioXcel Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $10
Current: $1.17
Upside: +754.70%
Balchem
May 6, 2024
Maintains: Buy
Price Target: $167 → $170
Current: $174.81
Upside: -2.75%
Cardiff Oncology
May 6, 2024
Reiterates: Buy
Price Target: $14
Current: $2.37
Upside: +491.97%
Cingulate
Jan 5, 2024
Maintains: Buy
Price Target: $3.5 → $8
Current: $0.38
Upside: +2,005.26%
Eton Pharmaceuticals
Dec 11, 2023
Reiterates: Buy
Price Target: $10
Current: $3.57
Upside: +180.11%
PaxMedica
Dec 4, 2023
Initiates: Buy
Price Target: $3
Current: $0.24
Upside: +1,150.00%
Protalix BioTherapeutics
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%
Aeterna Zentaris
Nov 13, 2023
Maintains: Buy
Price Target: $112 → $60
Current: $5.54
Upside: +983.03%
Galecto
Sep 28, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Ensysce Biosciences
Sep 25, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $0.41
Upside: +1,594.92%
Anebulo Pharmaceuticals
Sep 25, 2023
Reiterates: Buy
Price Target: $6
Current: $2.20
Upside: +172.73%
Galera Therapeutics
Aug 16, 2023
Downgrades: Neutral
Price Target: $6 → $0.3
Current: $0.13
Upside: +140.00%
Evofem Biosciences
Aug 15, 2022
Maintains: Buy
Price Target: $250 → $500
Current: $0.01
Upside: +4,237,188.14%
Addex Therapeutics
Jun 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $8.34
Upside: -
Tyra Biosciences
Jun 23, 2022
Initiates: Buy
Price Target: $12
Current: $20.35
Upside: -41.03%
InMed Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $0.28
Upside: -
Omeros
Oct 19, 2021
Maintains: Buy
Price Target: n/a
Current: $5.28
Upside: -
Synlogic
Oct 13, 2021
Maintains: Buy
Price Target: n/a
Current: $1.68
Upside: -
RedHill Biopharma
Sep 15, 2021
Maintains: Buy
Price Target: n/a
Current: $0.38
Upside: -
Immunic
Sep 7, 2021
Maintains: Buy
Price Target: n/a
Current: $1.39
Upside: -
Exicure
May 17, 2021
Maintains: Buy
Price Target: n/a
Current: $0.50
Upside: -
Repligen
May 5, 2021
Maintains: Buy
Price Target: n/a
Current: $132.36
Upside: -
Bausch Health Companies
Mar 16, 2021
Maintains: Buy
Price Target: n/a
Current: $5.88
Upside: -
TFF Pharmaceuticals
Mar 5, 2021
Maintains: Buy
Price Target: $775 → $925
Current: $1.77
Upside: +52,174.65%
NeuroBo Pharmaceuticals
Feb 1, 2021
Maintains: Buy
Price Target: $4,800 → $3,840
Current: $4.10
Upside: +93,672.89%
Applied DNA Sciences
Jan 14, 2021
Maintains: Buy
Price Target: $360 → $280
Current: $0.43
Upside: +65,782.35%
CareDx
Aug 5, 2020
Maintains: Buy
Price Target: n/a
Current: $18.87
Upside: -
CytoDyn
Jul 6, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.14
Upside: -
Replimune Group
Jul 1, 2020
Downgrades: Neutral
Price Target: n/a
Current: $10.48
Upside: -
IGM Biosciences
Jul 1, 2020
Initiates: Buy
Price Target: n/a
Current: $12.10
Upside: -
Evoke Pharma
Jun 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.48
Upside: -
BioLife Solutions
Mar 23, 2020
Maintains: Buy
Price Target: n/a
Current: $23.03
Upside: -
SpringWorks Therapeutics
Mar 19, 2020
Upgrades: Buy
Price Target: n/a
Current: $36.87
Upside: -
Celcuity
Nov 20, 2018
Initiates: Buy
Price Target: n/a
Current: $19.15
Upside: -
CytomX Therapeutics
Sep 13, 2018
Initiates: Buy
Price Target: n/a
Current: $1.42
Upside: -
Kala Pharmaceuticals
Aug 24, 2018
Maintains: Buy
Price Target: n/a
Current: $7.24
Upside: -
CorMedix
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $4.71
Upside: -
Check-Cap
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $2.02
Upside: -
T2 Biosystems
Mar 29, 2018
Maintains: Buy
Price Target: $40,000 → $42,500
Current: $4.83
Upside: +879,817.18%
DURECT
Mar 6, 2018
Upgrades: Buy
Price Target: n/a
Current: $1.65
Upside: -
DENTSPLY SIRONA
Mar 5, 2018
Maintains: Neutral
Price Target: n/a
Current: $26.43
Upside: -
Aethlon Medical
Nov 20, 2017
Initiates: Buy
Price Target: n/a
Current: $0.38
Upside: -
Bio-Path Holdings
Nov 13, 2017
Maintains: Buy
Price Target: $18,000 → $6,000
Current: $1.77
Upside: +338,061.53%
Immuron
Oct 18, 2017
Initiates: Buy
Price Target: n/a
Current: $2.29
Upside: -
Ocular Therapeutix
Jul 26, 2017
Initiates: Buy
Price Target: n/a
Current: $8.28
Upside: -
Alimera Sciences
Apr 27, 2017
Initiates: Buy
Price Target: n/a
Current: $5.59
Upside: -